Industry and FDA can—and must—do more to protect global pharmaceutical supply chains
Alan Coukell, Pew Prescription Project
Advertisement
Articles by Alan Coukell, Pew Prescription Project
Advertisement
Latest Updated Articles
- After Heparin: Protecting Consumers from the Risks of Substandard and Counterfeit Drugs
Published: August 28th 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
TrumpRx Launches With MFN-Based Drug Discounts
2
FTC–Express Scripts Settlement Targets PBM Rebates, Transparency, and Patient Drug Costs
3
How AI Orchestration Is Reinventing Healthcare Supply Chain Resilience
4
The Great Repricing: Commercial Channel Under Pressure
5